DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 2Alfred E Tiefenbacher GmbH
03 1NanoAlvand
04 1Pharmathen SA
05 4Accord healthcare
06 1Alkem Laboratories
07 1Alphapharm PTY Ltd
08 2Apotex Inc
09 1Arrow Pharmaceuticals
10 1Aurobindo Pharma Limited
11 1Biocon
12 1Bionpharma
13 1Bluepharma
14 1CHEMO
15 1Chartwell Pharmaceuticals llc
16 1Cipla
17 2Cycle Pharmaceuticals
18 1Deva Holding AS
19 2Devatis AG
20 1EZRA VENTURES
21 1Forrester Pharma
22 1Glenmark Pharmaceuticals
23 1HEC Pharm
24 1Hetero Drugs
25 2Intas Pharmaceuticals
26 1JAMP PHARMA
27 1MSN Laboratories
28 2Mepha Pharma
29 1Neuraxpharm
30 2Novartis Pharmaceuticals Australia Pty Limited
31 6Novartis Pharmaceuticals Corporation
32 1Novartis South Africa (Pty) Ltd
33 1ORIFARM GROUP AS
34 1Orchid Pharma
35 1Par Pharmaceutical
36 1Pharmacore Inc
37 1Pharmascience Inc.
38 1Prinston
39 4Sandoz B2B
40 1Standard Chem. & Pharm. Co., Ltd
41 2Sun Pharmaceutical Industries Limited
42 1Taro Pharmaceutical Industries
43 1Tecnimede
44 1Teva Pharma Australia
45 3Teva Pharmaceutical Industries
46 4Viatris
47 1Zydus Pharmaceuticals
01 1CAB
02 1CAP
03 11CAPSULE
04 23CAPSULE;ORAL
05 12Caps
06 6Capsule
07 1Capsule, hard
08 5Hard Capsule
09 1Hard Gelatin Capsule
10 2TABLET, ORALLY DISINTEGRATING;ORAL
11 8capsule
12 1Blank
01 3DISCN
02 1EU Approved
03 2EU Dossier Readiness-Q2 2018
04 2Generic
05 1Generic EU CTD
06 1Lead Market Dossiers- Filed
07 1Originator
08 19RX
09 42Blank
01 1ACH-FINGOLIMOD
02 1AKM Fingolimod
03 1APO-FINGOLIMOD
04 1Danelvin
05 3FINGOLIMOD
06 18FINGOLIMOD HYDROCHLORIDE
07 1FINGOLIS
08 2Fingolimod Accord
09 2Fingolimod Devatis
10 1Fingolimod SUN
11 3Fingolimod Sandoz
12 2Fingolimod Viatris
13 2Fingolimod-Mepha
14 1Fingolimod-Teva
15 1Fynod
16 4GILENYA
17 5Gilenya
18 1JAMP FINGOLIMOD
19 1MYLAN-FINGOLIMOD
20 1Myelenea
21 1PMS-FINGOLIMOD
22 1Pharmacor Fingolimod
23 1SANDOZ FINGOLIMOD
24 1TARO-FINGOLIMOD
25 2TASCENSO ODT
26 1TEVA-FINGOLIMOD
27 1Tugivin 0,5 mg
28 12Blank
01 9Australia
02 10Canada
03 2Germany
04 1Greece
05 4India
06 1Iran
07 1Norway
08 2Portugal
09 2South Africa
10 2Spain
11 12Switzerland
12 1Turkey
13 25USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2021-03-05
Application Number : 208000
Regulatory Info : RX
Registration Country : USA
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q2 2018
Registration Country : Germany
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q2 2018
Registration Country : Germany
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Danelvin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q2 2018
Registration Country : Germany
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q2 2018
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-10-28
Application Number : 207991
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-12-30
Application Number : 208004
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-12-18
Application Number : 207993
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2024-02-28
Application Number : 207983
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2019-12-04
Application Number : 207979
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2023-05-24
Application Number : 210252
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-06-29
Application Number : 207971
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TASCENSO ODT
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : EQ 0.25MG BASE
Packaging :
Approval Date : 2021-12-23
Application Number : 214962
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TASCENSO ODT
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2022-12-09
Application Number : 214962
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-06-18
Application Number : 207985
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2021-11-10
Application Number : 207939
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-05-18
Application Number : 207933
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FINGOLIMOD
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number : 208559
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GILENYA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2010-09-21
Application Number : 22527
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GILENYA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.25MG BASE
Packaging :
Approval Date : 2018-05-11
Application Number : 22527
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FINGOLIMOD
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number : 207965
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2022-09-07
Application Number : 208003
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FINGOLIMOD
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date :
Application Number : 207940
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2019-12-04
Application Number : 208014
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-07-02
Application Number : 208008
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.25MG BASE
Packaging :
Approval Date : 2021-11-12
Application Number : 212152
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2021-01-19
Application Number : 208005
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-10-14
Application Number : 207994
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2023-12-06
Application Number : 207945
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
